The nation of Zimbabwe has declined a substantial US health deal valued at $367m (£272m) over five years over Washington's insistence on confidential information.
The decision became public after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman has since clarified that the United States was requesting biological samples for research and commercial purposes but refused to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued talks to reach a agreement agreeable to both sides so the nation's vital HIV programme can continue.
Broader Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
As per statements, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining structures already set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome further dialogue with our US partners on how subsequent collaboration might be structured in a way that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed since much of the nation's HIV programmes depended on external financing.
"If specific concerns arise, such as those relating to information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group added.
The halted deal emphasises the complex debate between receiving crucial international aid and protecting national sovereignty in an ever more data-driven world.